How New GLP-1 Therapies Are Transforming Heart and Kidney Health with James Papatzimas

What if one therapy could support heart health, kidney health, metabolic health, and more? In this episode of the True North Success Podcast, Amy Kim sits down with James Papatzimas to explore how new GLP-1 therapies are changing the way cardiovascular and kidney disease are being approached.

James shares his journey from studying chemistry in Canada, to advanced research roles in California, and back home again in a medical science liaison role supporting physicians across Western Canada. He explains how his background in research and development gives him a unique perspective when working with healthcare providers and translating complex science into real-world patient impact.

The conversation dives into how GLP-1 receptor agonists have evolved beyond diabetes and weight management, showing promising benefits for cardiovascular and kidney health. James highlights why treating patients more holistically is becoming increasingly important, and how modern therapies are helping address unmet needs that traditional treatments cannot fully solve on their own.

James also opens up about the challenges of working in research, learning to grow from failure, navigating career uncertainty during the pandemic, and finding ways to bring global expertise back to Canada. He shares thoughtful insights on long-term career stability, consulting opportunities, and why finding meaningful work matters just as much as financial success.

---------------------------------------- Be a Guest Are you a successful business owner, entrepreneur, or professional with insights to share? Apply to be a guest at https://truenorthsuccessshow.com/guest and share your expertise with a wide audience eager to learn about you...